美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
69452-252-87	69452-252	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20210601	N/A	ANDA	ANDA212918	Bionpharma Inc.	ATOVAQUONE	750 mg/5mL	1 BOTTLE in 1 CARTON (69452-252-87) / 210 mL in 1 BOTTLE
73141-104-42	73141-104	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20241129	N/A	ANDA	ANDA212918	A2A Integrated Pharmaceuticals, LLC	ATOVAQUONE	750 mg/5mL	42 CUP, UNIT-DOSE in 1 CARTON (73141-104-42) / 5 mL in 1 CUP, UNIT-DOSE (73141-104-05)
81033-104-22	81033-104	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20250915	N/A	ANDA	ANDA212918	Kesin Pharma	ATOVAQUONE	750 mg/5mL	20 CUP, UNIT-DOSE in 1 CARTON (81033-104-22) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)
81033-104-42	81033-104	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20240617	N/A	ANDA	ANDA212918	Kesin Pharma	ATOVAQUONE	750 mg/5mL	42 CUP, UNIT-DOSE in 1 CARTON (81033-104-42) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)
81033-104-50	81033-104	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20240617	N/A	ANDA	ANDA212918	Kesin Pharma	ATOVAQUONE	750 mg/5mL	50 CUP, UNIT-DOSE in 1 CARTON (81033-104-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)
51407-642-87	51407-642	HUMAN PRESCRIPTION DRUG	Atovaquone	Atovaquone	SUSPENSION	ORAL	20220314	N/A	ANDA	ANDA212918	Golden State Medical Supply, Inc.	ATOVAQUONE	750 mg/5mL	1 BOTTLE in 1 CARTON (51407-642-87) / 210 mL in 1 BOTTLE